Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-09

FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ALBUTEROL SULFATE HFA from Teva Pharmaceuticals USA, Inc., related to this albuterol sulfate inhalation product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALBUTEROL SULFATE HFA (Albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE HFA (ALBUTEROL SULFATE)